Posted by Michael Wonder on 31 Jan 2023
Call for Enhertu to be registered on Pharmaceutical Benefits Scheme
31 January 2023 - Sarah Lee has been forced to use her super and life insurance to pay for the treatment.
A growing number of Australians diagnosed with breast cancer are calling on the federal government to subsidise the cost of Enhertu, a drug used to treat people with a specific variant of the deadly disease.
